EXC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Exelon Corp (EXC) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock benefits from positive technical indicators, strong hedge fund interest, and favorable long-term growth prospects in the utility sector. Despite recent financial performance challenges, the company's dividend yield, anticipated growth in load demand, and defensive nature during market volatility make it a solid long-term investment.
The technical indicators for EXC are generally positive. The MACD is above zero and contracting positively, RSI is neutral at 57.004, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level of 49.648, suggesting potential upward movement.
Hedge funds are heavily buying EXC, with a 2344.75% increase in buying over the last quarter.
Analysts have raised price targets recently, with multiple firms setting targets at or above the current price.
The utility sector is considered defensive during market volatility, and EXC is expected to benefit from increased demand for electricity driven by AI data centers.
The company has a stable dividend yield of 3.5%.
Recent financial performance shows declines in revenue (-1.08% YoY), net income (-8.19% YoY), and EPS (-7.81% YoY) for Q4
Regulatory and political challenges in key states may pose risks to growth.
Wolfe Research downgraded the stock, citing below-average earnings growth of 5%-7%.
In Q4 2025, Exelon reported a revenue decline of -1.08% YoY to $5.41 billion, net income dropped -8.19% YoY to $594 million, and EPS decreased -7.81% YoY to $0.59. However, gross margin improved by 11.50% YoY to 54.19%, reflecting efficiency gains.
Analyst sentiment is mixed but leans positive. KeyBanc raised its price target to $44 with an Underweight rating, while UBS, Morgan Stanley, BMO Capital, and Mizuho have price targets between $51 and $54 with Neutral to Outperform ratings. Wolfe Research downgraded the stock, citing political and regulatory risks, but the majority of analysts remain optimistic about long-term growth prospects.
